manifestări extrahepatice în hepatitele cronice la copil - Gr.T. Popa
manifestări extrahepatice în hepatitele cronice la copil - Gr.T. Popa
manifestări extrahepatice în hepatitele cronice la copil - Gr.T. Popa
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
218. Negro, F, Clement, S, Impact of obesity, steatosis and insulin resistance on<br />
progression and response to therapy of hepatitis C, J of Vir Hep, Oct 2009,<br />
16(10):681-688<br />
219. Su T.C, Chronic hepatitis B virus infection and dyslipidemia, Journ of the<br />
Formosan Medical Association, 2004, vol. 103, n o 4, pp. 286-291<br />
220. Deterding K.et al. Gilberts syndrome and antiviral therapy of chronic<br />
hepatitis C, Ann of Hepatol, jul-sept, vol8, no3,2009:246-250<br />
221. Cribier B, Urticaria and hepatitis, Clin Rev Allergy Immunol. 2006;<br />
30(1):25-9<br />
222. Vaida GA; Goldman MA; Bloch KJ, Testing for hepatitis B virus in<br />
patients with chronic urticaria and angioedema, J Allergy Clin Immunol. 1983;<br />
72(2):193-8<br />
223. Băicuş C., Medicina bazată pe dovezi: Cum <strong>în</strong>ţelegem studiile; Bucureşti<br />
Ed.Medicală, 2007:24-37<br />
224. Băicuş C., Dicţionar de epidemiologie clinică şi medicină bazată pe<br />
dovezi, Bucureşti, Ed.Medicală 2001:33-36<br />
225. Azoicăi D.,Boiculese L., Pisică-Donose G., Noţiuni de metodologie<br />
epidemiologică şi statistică medicală, Iaşi, Ed. Dan, 2001: 22-41<br />
226. Azoicăi D., Ancheta epidemiologică <strong>în</strong> practica medicală, Iaşi,<br />
Ed.Polirom, 1998:12-16<br />
227. K Moriya, K Nakagawa, T Santa, Y Shintani, H Fujie, H Miyoshi, T<br />
Tsutsumi, T Miyazawa, K Ishibashi, T Horie, K Imai, T Todoroki, S Kimura, K<br />
Koike, Oxidative stress in the absence of inf<strong>la</strong>mmation in a mouse model for<br />
hepatitis C virus-ass, Cancer Res (2001) 61: 4365-70<br />
228. Tel'nykh IuV, Maevskaia MV, Glushenkov DV, The use of<br />
hepatoprotector LiverPro in combined therapy of chronic viral hepatitis C, Klin<br />
Med (Mosk). 2008;86(11):60-2<br />
229. M. Nishioka Treatment of interferon non –responder patients with chronic<br />
hepatits C in Asia Chronic hepatitis:metabolic,cholestatic,viral and autoimmune<br />
ed Duke University MedicalCcenter,Durham , NC,USA<br />
230. Tsubota A, Kumada H, Arase Y et al Combined ursodeoxyicolic acid and<br />
glycyrrhizin therapy for chronic hepatitits C virus infection: a randomized<br />
controled trial in 170 patients. Eur, J. Gastroeterol Hepatol. 1999; 11: 1077-83<br />
231. Ikeda K, Arase Y, Kobayashi M et. Al. A long- term glycyrrhizin therapy<br />
injection reduces hepatocellu<strong>la</strong>r carciongenesis rate in patients with interferon<br />
resistant active chronic hepatitis C: a cohort study of 1249 patients. Dig. Dis Sci.<br />
2006; 5; 603-9<br />
232. Choi, J, Ou JHJ, Mechanisms of Liver Injury. III. Oxidative stress in the<br />
pathogenesis of hepatitis C virus, Am J of Phys, May 2006, 290(5 ),847-851<br />
233. Abdal<strong>la</strong> MY, Ahmad IM, Spity DR, et al. Hepatitis C virus-core and<br />
nonstructural proteins lead to different effects on cellu<strong>la</strong>r antioxidant defenses. J<br />
Med Virol. 2005; 76: 489-497<br />
234. Bureau C, Bernard J, Chaouche N, et al. Nonstructral 3 protein hepatitis C<br />
virus triggers an oxidative burst in human monocytes via activation of NADPH<br />
oxidase. J Biol Chem. 2001; 276: 23077-23083
Change language